The blood-brain barrier controls the exchange of substances between the blood and the brain. It protects the brain from toxins and pathogens, but at the same time it can make the delivery of therapeutic agents to the brain more difficult.
This report contains market size and forecasts of Blood Brain Barrier Technologies in Global, including the following market information:
Global Blood Brain Barrier Technologies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Blood Brain Barrier Technologies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bispecific Antibody RMT Approach Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Blood Brain Barrier Technologies include Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., Eli Lilly and Company., Bristol-Myers Squibb Company, Pfizer, Inc., Johnson and Johnson Services, Inc., Fabre-Kramer Pharmaceuticals, Inc., Bioasis Technologies Inc. and Abliva AB and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blood Brain Barrier Technologies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blood Brain Barrier Technologies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Blood Brain Barrier Technologies Market Segment Percentages, by Type, 2021 (%)
Bispecific Antibody RMT Approach
Trojan Horse Approach
Increasing Permeability
Passive Diffusion
Others
Global Blood Brain Barrier Technologies Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Blood Brain Barrier Technologies Market Segment Percentages, by Application, 2021 (%)
Alzheimer’s Disease
Epilepsy
Parkinson’s Disease
Multiple Sclerosis
Hunter’s Syndrome
Brain Cancer
Others
Global Blood Brain Barrier Technologies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Blood Brain Barrier Technologies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood Brain Barrier Technologies revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Blood Brain Barrier Technologies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company.
Bristol-Myers Squibb Company
Pfizer, Inc.
Johnson and Johnson Services, Inc.
Fabre-Kramer Pharmaceuticals, Inc.
Bioasis Technologies Inc.
Abliva AB
JCR Pharmaceuticals Co., Ltd.